Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Prostatic Hyperplasia × Clear all

Phase

Phase NA 3 Phase 2 2 Phase 4 1

Status

Unknown 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 30 Prostatic Neoplasms 12 Neoplasms 12 Carcinoma, Hepatocellular 9 Multiple Myeloma 8 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Papillomavirus Infections 7 Lung Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Liver Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Kidney Neoplasms 4 Heart Failure 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Febrile Neutropenia 3

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Finasteride 1 Dutasteride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡